DrugPatentWatch Database Preview
EPLERENONE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Eplerenone patents expire, and when can generic versions of Eplerenone launch?
The generic ingredient in EPLERENONE is eplerenone. There are four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the eplerenone profile page.
Summary for EPLERENONE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Suppliers / Packagers: | 7 |
| Bulk Api Vendors: | 42 |
| Clinical Trials: | 93 |
| Patent Applications: | 2,380 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | EPLERENONE at DailyMed |
Pharmacology for EPLERENONE
| Drug Class | Aldosterone Antagonist |
| Mechanism of Action | Aldosterone Antagonists |
Synonyms for EPLERENONE
| (+)-Eplerenone |
| (7?,11?,17?)-9,11-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid ?-lactone methyl ester |
| 107724-20-9 |
| 54272-EP2270011A1 |
| 54272-EP2298779A1 |
| 54272-EP2308562A2 |
| 6995V82D0B |
| 7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone |
| 9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic Acid gamma-Lactone Methyl Ester |
| 9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester |
| AB01274707_02 |
| AB01274707-01 |
| AB2000235 |
| AC-4213 |
| AC1L9FDC |
| AKOS015962307 |
| AX8041152 |
| BC210409 |
| BDBM50318300 |
| C12512 |
| CAS-107724-20-9 |
| Cgp 30083 |
| CGP-30083 |
| CGP30083 |
| CHEBI:31547 |
| CHEMBL1095097 |
| CS-2231 |
| D01115 |
| D0Q4SD |
| DB00700 |
| DR002506 |
| DSSTox_CID_26094 |
| DSSTox_GSID_46094 |
| DSSTox_RID_81333 |
| DTXSID2046094 |
| E0905 |
| Epleremone |
| Eplerenone (JAN/USAN/INN) |
| Eplerenone (JP17/USAN/INN) |
| Eplerenone [USAN:INN:BAN] |
| Eplerenone [USAN] |
| Eplerenone, >=98% (HPLC) |
| Epoxymexrenone |
| Epoxymexrenone;CGP30083;SC-66110 |
| GTPL2876 |
| HSDB 7522 |
| HY-B0251 |
| Inspra |
| Inspra (TN) |
| Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone |
| JUKPWJGBANNWMW-VWBFHTRKSA-N |
| KS-1406 |
| methyl (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate |
| methyl (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0;{1,17}.0;{2,7}.0;{11,15}]octadecan]-6'-ene-9'-carboxylate |
| METHYL (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-DIMETHYL-5,5'-DIOXO-18'-OXASPIRO[OXOLANE-2,14'-PENTACYCLO[8.8.0.0(1),(1)?.0(2),?.0(1)(1),(1)?]OCTADECAN]-6'-ENE-9'-CARBOXYLATE |
| methyl (4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-4a,6a-dimethyl-2,5'-dioxo-2,4,4a,4',5a,5',6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3'H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,2'-furan]-10-ca |
| methyl dimethyl-5'-dioxo-spiro[[?]-[?],2'-tetrahydrofuran]carboxylate |
| MolPort-003-986-216 |
| NCGC00159559-02 |
| NCGC00159559-03 |
| PL041004 |
| Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, gamma-lactone, methyl ester, (7alpha,11alpha,17alpha)- |
| s1707 |
| SC 6110 |
| SC-66110 |
| SC-6611O |
| SCHEMBL21515 |
| Selara |
| SR-01000942233 |
| SR-01000942233-1 |
| TL8000270 |
| Tox21_111746 |
| Tox21_111746_1 |
| UNII-6995V82D0B |
| YNU |
| ZINC3985982 |
US Patents and Regulatory Information for EPLERENONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | EPLERENONE | eplerenone | TABLET;ORAL | 206922-001 | Jul 13, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Sandoz | EPLERENONE | eplerenone | TABLET;ORAL | 078510-001 | Aug 1, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Apotex | EPLERENONE | eplerenone | TABLET;ORAL | 078482-002 | Jul 30, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Sandoz | EPLERENONE | eplerenone | TABLET;ORAL | 078510-002 | Aug 1, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
